HUP0101748A3 - Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders - Google Patents
Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disordersInfo
- Publication number
- HUP0101748A3 HUP0101748A3 HU0101748A HUP0101748A HUP0101748A3 HU P0101748 A3 HUP0101748 A3 HU P0101748A3 HU 0101748 A HU0101748 A HU 0101748A HU P0101748 A HUP0101748 A HU P0101748A HU P0101748 A3 HUP0101748 A3 HU P0101748A3
- Authority
- HU
- Hungary
- Prior art keywords
- reboxetine
- pharmaceutical compositions
- compositions suitable
- nervous disorders
- producing pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical compound CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 title 1
- 229960003770 reboxetine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Mobile Radio Communication Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8163298P | 1998-04-13 | 1998-04-13 | |
| IT98MI000870 IT1305322B1 (it) | 1998-04-23 | 1998-04-23 | Uso di reboxetina per il trattamento di disturbi nervosi |
| US8503398P | 1998-05-11 | 1998-05-11 | |
| PCT/US1999/004288 WO1999052518A2 (en) | 1998-04-13 | 1999-04-02 | New treatments for nervous disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101748A2 HUP0101748A2 (hu) | 2001-11-28 |
| HUP0101748A3 true HUP0101748A3 (en) | 2001-12-28 |
Family
ID=11379879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101748A HUP0101748A3 (en) | 1998-04-13 | 1999-04-02 | Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6391876B1 (hu) |
| EP (1) | EP1071418B1 (hu) |
| JP (1) | JP2002511408A (hu) |
| KR (1) | KR100555279B1 (hu) |
| CN (1) | CN1197569C (hu) |
| AT (1) | ATE277617T1 (hu) |
| AU (1) | AU755612B2 (hu) |
| BR (1) | BR9909476A (hu) |
| CA (1) | CA2320722A1 (hu) |
| DE (1) | DE69920679T2 (hu) |
| DK (1) | DK1071418T3 (hu) |
| EA (1) | EA003546B1 (hu) |
| ES (1) | ES2228035T3 (hu) |
| HU (1) | HUP0101748A3 (hu) |
| IL (1) | IL138887A0 (hu) |
| IT (1) | IT1305322B1 (hu) |
| NO (1) | NO20005131L (hu) |
| NZ (1) | NZ507693A (hu) |
| PL (1) | PL194039B1 (hu) |
| PT (1) | PT1071418E (hu) |
| SI (1) | SI1071418T1 (hu) |
| SK (1) | SK14482000A3 (hu) |
| TR (1) | TR200002970T2 (hu) |
| WO (1) | WO1999052518A2 (hu) |
| ZA (1) | ZA200004480B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500827B2 (en) * | 1998-05-08 | 2002-12-31 | Pharmacia & Upjohn Company | Drug combinations |
| ES2246485T3 (es) | 1999-07-01 | 2006-02-16 | PHARMACIA & UPJOHN COMPANY LLC | (s,s)-reboxetina para tratar la incontinencia. |
| EP1459751B1 (en) * | 1999-07-01 | 2005-09-14 | Pharmacia & Upjohn Company LLC | (S,S)-reboxetine for treating migraine headaches |
| EA200300567A1 (ru) * | 2000-11-15 | 2004-10-28 | Эли Лилли Энд Компани | Лечение состояний тревоги |
| PL375211A1 (en) * | 2002-06-17 | 2005-11-28 | Pharmacia Italia S.P.A. | Pharmaceutical salts of reboxetine |
| US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL56369A (en) | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| GB8419683D0 (en) | 1984-08-02 | 1984-09-05 | Erba Farmitalia | 3-substituted derivatives of 1-amino-2-hydroxy-propane |
| GB2167407B (en) | 1984-11-22 | 1988-05-11 | Erba Farmitalia | Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof |
| JP2001520195A (ja) | 1997-10-17 | 2001-10-30 | イーライ・リリー・アンド・カンパニー | 医薬の増強 |
-
1998
- 1998-04-23 IT IT98MI000870 patent/IT1305322B1/it active
-
1999
- 1999-04-02 CN CNB99804010XA patent/CN1197569C/zh not_active Expired - Fee Related
- 1999-04-02 US US09/673,768 patent/US6391876B1/en not_active Expired - Fee Related
- 1999-04-02 IL IL13888799A patent/IL138887A0/xx not_active IP Right Cessation
- 1999-04-02 EP EP99918423A patent/EP1071418B1/en not_active Expired - Lifetime
- 1999-04-02 SK SK1448-2000A patent/SK14482000A3/sk unknown
- 1999-04-02 PT PT99918423T patent/PT1071418E/pt unknown
- 1999-04-02 BR BR9909476-2A patent/BR9909476A/pt not_active Application Discontinuation
- 1999-04-02 TR TR2000/02970T patent/TR200002970T2/xx unknown
- 1999-04-02 JP JP2000543128A patent/JP2002511408A/ja active Pending
- 1999-04-02 ES ES99918423T patent/ES2228035T3/es not_active Expired - Lifetime
- 1999-04-02 WO PCT/US1999/004288 patent/WO1999052518A2/en active IP Right Grant
- 1999-04-02 CA CA002320722A patent/CA2320722A1/en not_active Abandoned
- 1999-04-02 KR KR1020007011336A patent/KR100555279B1/ko not_active IP Right Cessation
- 1999-04-02 PL PL99346294A patent/PL194039B1/pl unknown
- 1999-04-02 DK DK99918423T patent/DK1071418T3/da active
- 1999-04-02 AU AU36351/99A patent/AU755612B2/en not_active Ceased
- 1999-04-02 NZ NZ507693A patent/NZ507693A/en unknown
- 1999-04-02 EA EA200001058A patent/EA003546B1/ru not_active IP Right Cessation
- 1999-04-02 DE DE69920679T patent/DE69920679T2/de not_active Expired - Fee Related
- 1999-04-02 AT AT99918423T patent/ATE277617T1/de not_active IP Right Cessation
- 1999-04-02 SI SI9930684T patent/SI1071418T1/xx unknown
- 1999-04-02 HU HU0101748A patent/HUP0101748A3/hu active IP Right Revival
-
2000
- 2000-08-29 ZA ZA200004480A patent/ZA200004480B/en unknown
- 2000-10-12 NO NO20005131A patent/NO20005131L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL138129A (en) | Composition for therapy of estrogen-associated disorders | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| PL351134A1 (en) | Compositions for treatment of disorders of the oesophagus | |
| IL139591A0 (en) | Combination therapy for treatment of bipolar disorders | |
| HUP0301167A3 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use | |
| IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| HUP9904525A3 (en) | Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| IL143921A0 (en) | Compositions for the treatment and prevention of tumors and tumor-related disorders | |
| HUP0102203A3 (en) | Use of optically pure(+)-norcisapride for producing pharmaceutical compositions suitable for treating apnea, bulimia and other disorders | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| HUP9701193A3 (en) | Use of n-(4-aryl-thiazol-2-yl)-sulfonamide derivatives for the preparation of pharmaceutical compositions treating neurological disorders, new derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0501017A3 (en) | Methods and compositions for treatment of central nervous system disorders | |
| IL141263A0 (en) | Methods for treatment of neurological disorders | |
| IL112895A (en) | Pharmaceutical compositions for the treatment of obsessive-compulsive disorders comprising 5-HT2 antagonists | |
| HUP0102436A3 (en) | Use of reboxetin for preparation of medicament for nervous disorders | |
| HUP0100080A3 (en) | Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas | |
| HUP0103832A3 (en) | Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof | |
| AU2002362115A8 (en) | Composition and methods for treatment of neurological disorders | |
| IL132972A0 (en) | Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders | |
| GB9926968D0 (en) | Treatment of neurological disorders | |
| HUP0102532A3 (en) | Aza-heterocyclic compounds used to treat neurological disorders and hair loss and process for their preparation and pharmaceutical compositions containing them | |
| HUP0101748A3 (en) | Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders | |
| HUP0301553A3 (en) | Pharmaceutical compositions and their use for treating neurological disorders | |
| HUP0102026A3 (en) | Use of optically pure (-) norcisapride for producing pharmaceutical compositions suitable for treating apnea, bulimis, and other disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees | ||
| NF4A | Restoration of patent protection | ||
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |